Website www.epocrates.com Parent organization athenahealth | Founded 1998 | |
 | ||
Headquarters San Mateo, California, United States Profiles | ||
Epocrates founders story
Epocrates, Inc. is an American company based in San Francisco, California that makes various mobile health software applications under the "epocrates" name, mostly for health care providers, providing them reference information about drugs and diseases, and diagnostic tools.
Contents
Epocrates drug interaction app on the galaxy tab targets doctors
Products
Epocrates is a publisher of mobile device software applications, designed to provide information about drugs to doctors and other health care professionals. Among the software functions is checking for drug interactions, news feeds for product announcements and medical news, journal article lookup, as well as a mobile guide to ICD-9 and Current Procedural Terminology ("CPT") diagnosis codes. The application is widely available and sometimes free. One can download the application easily to an iPhone or Android device, so it is easily accessible.
The company markets both free and multiple paid versions. It receives additional revenue from pharmaceutical companies.
The company was founded in 1998. Early versions of epocrates ran on Palm devices and desktop computers. The user base was 525,000 users worldwide (including 200,000 doctors in the United States) in 2006. As of 2006, the company was also active in the United Kingdom, Canada, Germany and Spain. Among its competitors is WebMD. By 2010, the company said it had 1 million users worldwide, including 40% of the physicians in the United States, and that it employed more than 250 people.
Management team
Jonathan Bush – CEO
Rob Cosinuke – President
Heather Gervais – Senior Vice President, Commercial Operations
Dr. Anne Meneghetti – Executive Director of Medical Information
History
Epocrates' early funders included Bay City Capital, Draper Fisher Jurvetson, Interwest Partners, Sprout Group and Three Arch Partners.
After a 2008 public offering was put on hold, Epocrates filed a registration statement again in July 2010 to raise $75 million.
On January 7, 2013, it was announced that athenahealth is acquiring Epocrates for about $293 million.